Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. | ||
| Egyptian Journal of Medical Research | ||
| Article 9, Volume 1, Issue 1, January 2020, Pages 107-121 PDF (564.37 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejmr.2020.89076 | ||
| Authors | ||
| Mansour Hassan Ahmad Hassan1; Mohamed Osman2; Waleed El-Nabawy3; Alzahraa Yasseen Sayed* 1 | ||
| 1Ophthalmology department, Faculty of Medicine, Beni-Suef University, Egypt | ||
| 2Ophthalmology department, Faculty of Medicine, Beni-Suef University, Egypt. | ||
| 3Internal medicine department, Faculty of Medicine, Beni-Suef University, Egypt | ||
| Abstract | ||
| Background: Chronic Hepatitis C is common problem worldwide treated by combination of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy. Aim: determine the frequency and risk factors of retinopathy in patients with chronic hepatitis C treated by interferon and ribavirin combination therapy in Egypt. Methods and Results: Total 100 patients were enrolled among which, 16 (16%) developed retinopathy in the form of cotton wool spots and 14(14%) developed atypical complications. Conclusion: Retinopathy may occur in patients with chronic hepatitis C receiving interferon alpha and ribavirin. | ||
| Keywords | ||
| Retinopathy; Interferon; ribavirin; chronic hepatitis C | ||
|
Statistics Article View: 315 PDF Download: 445 |
||
